Navigation Links
Cosmetic Eye Enhancer may Lead to Disfigurement

Polylactic acid (PLA), used as a cosmetic enhancement to decrease volume loss around the eyes, leads to disfigurement when not injected properly . The authors reviewed four cases where patients were injected superficially; all four exhibited nodule development and inflammation.

PLA should not be injected superficially, especially around the eyes, says study author and dermatologist Greg Goodman. This material does not act as a dermal filler, which would be injected superficially to smooth wrinkles, but needs to be placed deeply below the muscles to be a safer and more effective agent.

The technique is still so comparatively new and unproven, however, that Goodman cautions against its use around the eyes unless completed by a doctor who is experienced in its use.

According to Goodman, many cosmetic techniques are implemented too quickly and too carelessly. Practitioners should be wary of new procedures and instruction from representatives who themselves have been recently trained in the procedures, says Goodman.

Goodman also cautions patients against trying the newest products on the market. New procedures are not necessarily the best procedures; sometimes waiting for a procedure to improve and mature over many years is the best policy for those seeking safe, quality results.


'"/>




Page: 1

Related medicine news :

1. Cosmetic plastic surgery for a youthful healthy look
2. How Safe Are Your Cosmetics ?
3. “Yes, I need Cosmetic surgery” – view of majority wome
4. Details of Cosmetic Surgery in a Special Website.
5. More People Come To India For Cosmetic Surgery
6. Transparency in Probable Outcomes of Cosmetic Surgeries Necessary
7. Cosmetic Surgeons Discuss Facelift Surgery
8. Chemical Content in Cosmetic Products may be Harmful for Health
9. Campaign Against Cosmetic Surgeries Performed By Less-Skilled Non-physicians Launched
10. Survey Finds Americans Not Averse To Cosmetic Surgery
11. Do Anti-wrinkle Cosmetics Really Work?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: